Allogeneic stem cell transplantation for mantle cell lymphoma (MCL): Evidence of graft-versus-lymphoma effect (GVL).

被引：0
作者：
Khouri, I
Korbling, M
Albitar, M
Przepiorka, D
Romaguera, J
Giralt, S
Claxton, D
Cabanillas, F
Champlin, R
机构：
[1] Univ Texas, MD Anderson Cancer Ctr, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Cancer Ctr, Dept Lymphoma & Lab Med, Houston, TX 77030 USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2708
引用
收藏
页码：656A / 656A
页数：1
相关论文
共 50 条
[31]   Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for Follicular Lymphoma and Clinical Evidence of Graft-Versus-Lymphoma Effect in Post-Transplant Relapsed Patients [J].
Kohashi, Sumiko ;
Mori, Takehiko ;
Kato, Jun ;
Kobayashi, Hikaru ;
Okamoto, Shinichiro .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) :S225-S225
[32]   Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy [J].
Khouri, IF ;
Lee, MS ;
Romaguera, J ;
Mirza, N ;
Kantarjian, H ;
Korbling, M ;
Albitar, M ;
Giralt, S ;
Samuels, B ;
Anderlini, P ;
Rodriguez, J ;
von Wolff, B ;
Gajewski, J ;
Cabanillas, F ;
Champlin, R .
ANNALS OF ONCOLOGY, 1999, 10 (11) :1293-1299
[33]   Allogeneic stem cell transplant (AlloSCT) for Hodgkin's lymphoma which has relapsed following autologous SCT - Evidence for potent graft-versus-lymphoma effect. [J].
Klein, AK ;
Geoffrey, C ;
Sprague, K ;
Miller, KB ;
Foss, F .
BLOOD, 2004, 104 (11) :909A-909A
[34]   Nonablative allogeneic stem cell transplantation for relapsed mantle cell lymphoma (MCL): A promising strategy for an aggressive disease. [J].
Khouri, IF ;
Lee, MS ;
Saliba, RM ;
Gu, J ;
Fayad, L ;
Hosing, C ;
Donato, ML ;
Pro, B ;
Couriel, D ;
Rodriguez, M ;
Korbling, M ;
Cabanillas, F ;
Ruth, K ;
Champlin, R .
BLOOD, 2002, 100 (11) :426A-427A
[35]   Non-myeloablative allogeneic stem cell transplantation in mantle cell lymphoma [J].
Le Gouill, S. ;
Kroeger, N. ;
Dhedin, N. ;
Nagler, A. ;
Bouabdallah, K. ;
Yakoub-Agha, I. ;
Bulabois, C-E ;
Buzyn, A. ;
Rio, B. ;
Moles, M-P. ;
Shimoni, A. ;
Guillaume, T. ;
Milpied, N. ;
Leux, C. ;
Harousseau, J-L. ;
Mohty, M. .
BONE MARROW TRANSPLANTATION, 2009, 43 :S67-S67
[36]   OUTCOMES OF MANTLE CELL LYMPHOMA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION [J].
Costa, R. ;
Palmer, J. ;
Shen, Y. ;
Paris, T. ;
Popplewell, L. ;
Kogut, N. M. ;
Forman, S. J. ;
Nademanee, A. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) :S330-S330
[37]   Allogeneic hematopoietic cell transplantation in mantle cell lymphoma [J].
Cassaday, Ryan D. ;
Gopal, Ajay K. .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2012, 25 (02) :165-174
[38]   Identification of APOBEC3B as a potential target for the graft-versus-lymphoma effect by SEREX in a patient with mantle cell lymphoma [J].
Hishizawa, M ;
Imada, K ;
Sakai, T ;
Ueda, M ;
Uchiyama, T .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (03) :418-421
[39]   Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma [J].
He, Simon ;
Roberts, Andrew ;
Ritchie, David ;
Grigg, Andrew .
LEUKEMIA & LYMPHOMA, 2007, 48 (07) :1448-1450
[40]   Allogeneic stem cell transplantation for lymphoma [J].
Valkova, V. ;
Benesova, K. ;
Vitek, A. ;
Faber, E. ;
Koristek, Z. ;
Zak, P. ;
Trneny, M. .
BONE MARROW TRANSPLANTATION, 2007, 39 :S146-S147
12345